ba0005p400 | Osteoporosis: treatment | ECTS2016
Kinoshita Mayuko
, Ishijima Muneaki
, Kaneko Haruka
, Lizu Liu
, Sadatsuki Ryo
, Hada Shinnnosuke
, Yusup Anwar
, Arita Hitoshi
, Shiozawa Jun
, Yamanaka Makoto
, Sakamoto Yuko
, Nojiri Hidetoshi
, Kaneko Kazuo
Background: It is important to increase bone mineral density (BMD) by the treatment with bisphosphonates (BPs), as lower BMD has been revealed to be one of the risk factors for the subsequent fragility fracture in patients with osteoporosis treated with BPs.Methods: The two independent populations of the patients with postmenopausal osteoporosis who were treated for 2y by BPs with active vitamin D analogue (aVD) were enrolled in Study 1 (n=93) a...